ArticleNutrients2026
Evaluation of the Naples Prognostic Score in Patients with Head and Neck Squamous Cell Carcinoma.
Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesSystemic inflammation and nutritional status are two factors known to influence the prognosis of cancer patients. The Naples Prognostic Score (NPS) includes two inflammatory and two nutritional markers and combines them in a single score to better predict survival of cancer patients. In this study, we aimed to critically evaluate the NPS for its significance in head and neck cancer patients.
methodsWe retrospectively analyzed the preoperative NPS and its association with overall survival (OS) and disease-free survival (DFS). We evaluated 140 patients with head and neck squamous cell carcinoma (HNSCC) who were treated with primary surgical therapy at a tertiary center between 2001 and 2019. OS and DFS were analyzed using Kaplan-Meier estimators, the log-rank test and uni- and multivariable Cox models.
resultsThe median postoperative follow-up was 6.7 years. Higher NPS showed numerically, but not significantly shorter OS and DFS. Sensitivity analysis for all markers included in the NPS revealed only the neutrophil-to-lymphocyte ratio (NLR) as a significant predictor for OS and DFS.
conclusionsThese findings suggest that the overall NPS may have limited prognostic value in this cohort. In contrast, NLR appears to be a more robust and clinically relevant marker for survival outcomes in patients with head and neck squamous cell carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.